Taplucainium chloride

N/A

Report date: 2025/06/26 20:00:07
NME

Base Information

Drug NameTaplucainium chloride
Drug Alias NameTaplucainiumNTX-1175
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type IX alpha subunit blockers
TargetsSodium channel protein type IX alpha subunit
Therapy Area/IndicationsCough
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNocion Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNocion Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCough
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A